Orchestra BioMed Holdings (OBIO) Enterprise Value (2020 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Enterprise Value came in at -$84.6 million in Q1 2026, down 69.65% year-on-year from -$278.8 million in Q1 2025, and up 42.28% on a QoQ basis from -$146.6 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) Enterprise Value (2020 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 7 years of Enterprise Value data on file, last reported at -$84.6 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 69.65% year-over-year to -$84.6 million in Q1 2026; TTM through Mar 2026 was -$84.6 million, a 69.65% decrease from a year earlier, with the FY2025 full-year figure at -$146.6 million, down 44.67% from the prior year.
- Enterprise Value for Q1 2026 stood at -$84.6 million, up from -$146.6 million in the prior quarter.
- Over the last five years, Enterprise Value for OBIO reached as high as -$735217.0 in Q3 2022 and fell as low as -$215.9 million in Q2 2023.
- Historically, Enterprise Value has averaged -$73.4 million across 5 years, with a median of -$84.6 million in 2026.
- Across the five-year window, Enterprise Value slumped 16418.84% in 2023 and soared 81.64% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$19.9 million in 2022, then slumped by 340.5% to -$87.5 million in 2023, then slipped by 15.79% to -$101.4 million in 2024, then sank by 44.67% to -$146.6 million in 2025, then surged by 42.28% to -$84.6 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$84.6 million in Q1 2026, -$146.6 million in Q4 2025, and -$95.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | -84.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.63 Mn |
| Dec 31, 2025 | -146.63 Mn |
| Sep 30, 2025 | -95.82 Mn |
| Jun 30, 2025 | -33.92 Mn |
| Mar 31, 2025 | -49.88 Mn |
| Dec 31, 2024 | -101.35 Mn |
| Sep 30, 2024 | -95.87 Mn |
| Jun 30, 2024 | -53.93 Mn |
| Mar 31, 2024 | -23.35 Mn |
| Dec 31, 2023 | -87.53 Mn |
| Sep 30, 2023 | -108.49 Mn |
| Jun 30, 2023 | -215.85 Mn |
| Mar 31, 2023 | -127.13 Mn |
| Dec 31, 2022 | -19.87 Mn |
| Sep 30, 2022 | -735,217.00 |
| Jun 30, 2022 | -1.31 Mn |
| Mar 31, 2022 | -1.42 Mn |
| Dec 31, 2021 | -1.75 Mn |
| Sep 30, 2021 | -1.78 Mn |
| Jun 30, 2021 | -1.91 Mn |